FDA Grants Interchangeability Designation to Yuflyma, Biosimilar for Humira Across All Approved Doses

Source: Pharmacy Times articles

Yuflyma gains FDA interchangeability with Humira, enhancing patient access to effective biosimilar treatments for various inflammatory conditions.
Read More